v3.26.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Sep. 30, 2025
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Accounts payable and accrued expenses $ 1,581,180     $ 1,581,180   $ 1,250,285
Equipment financed with note payable       $ 55,000 $ 48,191  
Accounts receivable concentration risk, percentage       10.00%    
Revenue recognition, sales returns, reserve for sales returns 0     $ 482,405    
Contract with customer, asset, sale 0     91,100    
Revenue recognition, milestone method, revenue recognized       $ 518,282    
Description of principal terms of the purchase order       Contract price: $4,880,000 firm fixed price, allocated $3,000,000 to the AirSCWO 6 unit, $1,140,000 to pretreatment equipment skids, $452,500 to one-time project fees, and $287,500 to an additional one-year extended warranty    
Billings in excess of cost           1,900,000
Revenue equipment receive   $ 100,000,000,000       1,900,000
Research and development cost 284,589   $ 531,170 $ 34,423 $ 1,064,757  
Revenue recognition, milestone method       2,296,250    
Revenue receive as consideration       812,000    
Unearned revenue           90,667
Contract with customer, asset           91,100
Inventory allowance $ 50,000     50,000   50,000
Contract loss provision       $ 1,000,000    
Unbilled Accounts Receivable [Member]            
Revenue equipment receive   $ 100,000,000,000       1,900,000
One Customer [Member] | Revenue [Member]            
Revenues concentration risk, percentage 88.00%   94.00% 88.00% 78.00%  
One Customer [Member] | Unbilled Accounts Receivable [Member]            
Accounts receivable concentration risk, percentage       100.00% 100.00%  
One Customer [Member] | Accounts Receivable [Member]            
Accounts receivable concentration risk, percentage       82.00% 74.00%  
Unvested Restricted Stock [Member]            
Antidilutive excluded from computation of earnings per share, amount       513,370 621,282  
Warrants [Member]            
Antidilutive excluded from computation of earnings per share, amount       1,864,191 1,467,524  
Options [Member]            
Antidilutive excluded from computation of earnings per share, amount       1,668,633 1,751,550  
Equipment [Member]            
Accounts payable and accrued expenses $ 55,000     $ 55,000    
Equipment financed with note payable       $ 55,000   $ 4,583